Our Pricing

Wegovy Duration & Transparent Pricing - No Hidden Fees

Published on: June 03, 2026

Understanding how long do you take Wegovy for is essential before starting treatment. At Cured Pharmacy, we provide transparent pricing from £79.00 with no hidden fees, alongside expert guidance on Wegovy's dosing schedule, maintenance phase, and long-term use from our UK-registered clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

How Long Do You Take Wegovy For: Treatment Duration Explained

Wegovy (semaglutide) is designed for long-term weight management rather than short-term use. Clinical trials demonstrate that optimal results occur when patients maintain treatment for at least 68 weeks, with many continuing beyond this timeframe subject to prescriber approval [1]. The STEP 1 trial showed that participants achieved an average 14.9% body weight reduction over 68 weeks, with weight loss plateauing around 60 weeks before stabilising [1].

Treatment typically begins with a 16-week titration phase, gradually increasing from 0.25mg weekly to the maintenance dose of 2.4mg weekly. This careful escalation minimises gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-regulating effects [2]. Once you reach the maintenance dose, most patients continue at 2.4mg weekly for as long as the medication remains clinically beneficial and well-tolerated.

Discontinuation studies reveal that stopping Wegovy often leads to weight regain. The STEP 4 trial found that patients who switched from semaglutide to placebo after 20 weeks regained approximately two-thirds of their lost weight over the following 48 weeks [3]. This evidence supports ongoing treatment for sustained weight management, though your UK prescriber will review your progress regularly to ensure continued suitability.

Wegovy Dosing Schedule: From Initiation to Maintenance

The Wegovy titration protocol follows a structured 16-week escalation designed to optimise tolerability. You'll start at 0.25mg once weekly for four weeks, then increase to 0.5mg for four weeks, followed by 1mg for four weeks, then 1.7mg for four weeks, before reaching the full maintenance dose of 2.4mg weekly [2].

This gradual approach is clinically proven to reduce the incidence of nausea, vomiting, and diarrhoea—the most commonly reported side effects during Wegovy initiation. If you experience persistent gastrointestinal symptoms at any dose level, your prescriber may recommend staying at your current dose for an additional four weeks before escalating further, ensuring treatment remains tolerable whilst maintaining efficacy.

Maintenance Phase: What to Expect Long-Term

Once you reach the 2.4mg maintenance dose, you'll typically continue at this level indefinitely, subject to ongoing clinical assessment. Your UK prescriber will monitor your weight loss progress, metabolic markers, and any side effects through regular reviews—usually every three to six months. If you achieve significant weight loss and maintain it successfully, your prescriber may discuss whether continued treatment remains appropriate for your individual circumstances.

Some patients remain on Wegovy for several years when it continues to support their weight management goals without problematic side effects. The decision to continue or discontinue treatment should always be made collaboratively with your prescriber, considering factors including weight maintenance, cardiovascular risk reduction, and overall quality of life improvements.

Transparent Wegovy Pricing at Cured Pharmacy: No Hidden Fees

At Cured Pharmacy, Wegovy pricing starts from £79.00 with complete transparency—the price you see is the price you pay, with no hidden consultation fees, no membership charges, and no surprise costs at checkout. Unlike some online providers who advertise low headline prices then add consultation fees or subscription costs, our pricing includes your free online clinical assessment by a UK-registered prescriber.

Your Wegovy prescription cost will depend on your prescribed dose during the titration phase and maintenance phase. We display all pricing upfront before you complete your free consultation, ensuring you can make an informed decision about your weight loss treatment without unexpected financial commitments. This transparent approach reflects our commitment to accessible, honest healthcare for UK patients.

Every Wegovy pen dispensed by Cured Pharmacy is UK-licensed, MHRA-approved, and sourced through legitimate pharmaceutical supply chains. We guarantee genuine medication at the lowest prices in the UK, backed by our GPhC-registered pharmacy (9012511) and experienced clinical team. Your prescription will arrive in 100% discreet packaging, with no branding or indication of contents visible on the exterior.

When to Stop Taking Wegovy: Clinical Guidance

Discontinuation of Wegovy should always be discussed with your prescriber rather than decided independently. Common reasons for stopping treatment include achieving your target weight and successfully maintaining it for several months, experiencing persistent side effects that outweigh benefits, or developing contraindications such as pregnancy or certain medical conditions.

If you haven't achieved at least 5% body weight reduction after 16 weeks at the maintenance dose, NICE guidance suggests reassessing whether Wegovy remains appropriate for you [4]. However, individual response varies, and your prescriber will consider multiple factors including metabolic improvements, waist circumference reduction, and cardiovascular risk factors—not just the number on the scales.

Should you and your prescriber decide to stop Wegovy, there's no medical requirement to taper the dose gradually. Unlike some medications, semaglutide can be discontinued abruptly without withdrawal symptoms. However, you'll need a structured plan for maintaining your weight loss through continued dietary modifications, physical activity, and behavioural strategies to minimise weight regain.

Managing Weight After Stopping Wegovy

Post-treatment weight management requires ongoing commitment to the lifestyle changes you've developed during Wegovy therapy. Research shows that patients who maintain structured eating patterns, regular physical activity, and behavioural support after discontinuation experience less weight regain than those who return to previous habits [3].

Your UK prescriber may recommend follow-up consultations after stopping Wegovy to monitor your weight trajectory and provide support if regain occurs. Some patients may benefit from restarting treatment if significant weight regain threatens their health, whilst others successfully maintain their weight loss through lifestyle measures alone. The key is individualised, ongoing clinical support rather than viewing Wegovy as a temporary fix.

Wegovy Long-Term Safety: What the Evidence Shows

Long-term safety data for semaglutide extends beyond five years from diabetes studies, with weight management trials now providing multi-year follow-up data. The STEP trials demonstrated that Wegovy remains well-tolerated during extended use, with most side effects occurring during dose escalation and diminishing over time [1][2].

The most significant safety finding emerged from the SELECT cardiovascular outcomes trial, which showed that semaglutide reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease over a median follow-up of 40 months [5]. This suggests that long-term Wegovy use may provide cardiovascular protection beyond weight loss alone, particularly for higher-risk patients.

Common long-term considerations include potential gallstone formation (occurring in approximately 1-2% of patients), theoretical concerns about thyroid C-cell tumours (observed in rodent studies but not confirmed in human populations), and the need for adequate protein intake to preserve lean muscle mass during weight loss [2]. Your UK prescriber will assess your individual risk factors and monitor for any emerging concerns during ongoing treatment.

How Long Do You Take Wegovy For: Personalising Your Treatment Journey

There's no universal answer to treatment duration because Wegovy responds differently to individual metabolic profiles, lifestyle factors, and weight loss goals. Some patients achieve their target weight within 12 months and transition to a maintenance approach, whilst others benefit from extended treatment spanning several years to address more substantial weight loss needs or prevent regain.

Your UK prescriber will establish personalised treatment milestones during your initial consultation, typically reviewing progress every 12-16 weeks. These reviews assess not just weight loss but also improvements in obesity-related conditions such as type 2 diabetes, hypertension, sleep apnoea, and joint pain. If Wegovy significantly improves these comorbidities alongside weight reduction, long-term continuation may be clinically justified even after reaching your weight goal.

At Cured Pharmacy, our clinical team takes a holistic approach to weight management, recognising that medication forms just one component of successful long-term outcomes. We provide ongoing support, dosing adjustments when needed, and transparent communication about treatment duration expectations—ensuring you feel confident and informed throughout your Wegovy journey.

Starting Your Wegovy Treatment with Cured Pharmacy

Beginning Wegovy treatment at Cured Pharmacy takes under three minutes with our streamlined online consultation. You'll complete a clinical questionnaire reviewed by a UK-registered prescriber who will assess your suitability for semaglutide therapy, considering your BMI, medical history, current medications, and weight loss goals.

If approved, your prescription will be dispensed by our GPhC-registered pharmacy and dispatched in discreet packaging with tracked delivery. You'll receive clear instructions on injection technique, dose escalation schedule, and when to expect follow-up reviews. Our clinical team remains available throughout your treatment for any questions or concerns, ensuring you receive expert support at every stage of your weight loss journey.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy (semaglutide) Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and requires approval from a UK prescriber following an online consultation. Individual results may vary. Weight loss outcomes depend on multiple factors including diet, exercise, and adherence to treatment.